DR. WILLIAM LANGLEY PRIDGEN, M.D.
Radiology at Commons North Dr, Tuscaloosa, AL
License number
Alabama 00022573
Category
Radiology
Type
Surgery
Address
Address
1837 Commons North Dr NORTH, Tuscaloosa, AL 35406
Phone
(205) 366-0696
(205) 366-1451 (Fax)
(205) 366-1451 (Fax)
Personal information
See more information about WILLIAM LANGLEY PRIDGEN at radaris.comName
Address
Phone
1788 Mcfarland Blvd N, Tuscaloosa, AL 35406
6300 Lake Vista Cir, Tuscaloosa, AL 35406
1837 Commons North Loop N, Tuscaloosa, AL 35406
1788 Mcfarland Blvd, Tuscaloosa, AL 35406
4036 State Highway 54, Kinston, AL 36453
Professional information
See more information about WILLIAM LANGLEY PRIDGEN at trustoria.com
William Langley Pridgen, Tuscaloosa AL
William Langley Pridgen, Tuscaloosa AL
Specialties:
Surgeon
Address:
1788 Mcfarland Blvd N, Tuscaloosa, AL 35406
1837 Commons North Dr, Tuscaloosa, AL 35406
1837 Commons North Dr, Tuscaloosa, AL 35406
Education:
Doctor of Medicine
Board certifications:
American Board of Surgery Certification in Surgery
William Langley Pridgen, Tuscaloosa AL
William Langley Pridgen, Tuscaloosa AL
Specialties:
Surgery
Work:
Northport Medical Center
1837 Commons North Dr, Tuscaloosa, AL 35406
1837 Commons North Dr, Tuscaloosa, AL 35406
Education:
University of Tennessee (1986)
Antiviral Compound And Cox-2 Inhibitor Combination Therapy For Functional Somatic Syndromes, Including Combination Of Famciclovir And Celecoxib
Antiviral Compound And Cox-2 Inhibitor Combination Therapy For Functional Somatic Syndromes, Including Combination Of Famciclovir And Celecoxib
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/761056
Inventors:
William L. Pridgen - Tuscaloosa AL, US
International Classification:
A61K 31/635, A61K 31/52
US Classification:
514158
Abstract:
The present invention relates to methods of treating fibromyalgia, by administering a therapeutically-effective combination of an antiviral component and a COX-2 inhibitor component. The invention is further related to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound famciclovir and a therapeutically-effective amount of the COX-2 inhibitor celecoxib. The invention is also related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of famciclovir and celecoxib.
Famciclovir And Meloxicam Combination Therapy For Functional Somatic Syndromes
Famciclovir And Meloxicam Combination Therapy For Functional Somatic Syndromes
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/761079
Inventors:
William L. Pridgen - Tuscaloosa AL, US
International Classification:
A61K 31/5415, A61K 31/52
US Classification:
5142265
Abstract:
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound famciclovir and a therapeutically-effective amount of the COX-2 inhibitor meloxicam. The invention is further related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of famciclovir and meloxicam.
Valaciclovir And Diclofenac Combination Therapy For Functional Somatic Syndromes
Valaciclovir And Diclofenac Combination Therapy For Functional Somatic Syndromes
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/761096
Inventors:
William L. Pridgen - Tuscaloosa AL, US
International Classification:
A61K 31/522, A61K 31/196
US Classification:
51426338
Abstract:
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound valaciclovir and a therapeutically-effective amount of the COX-2 inhibitor diclofenac. The invention is further related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of valaciclovir and diclofenac.
Valaciclovir And Meloxicam Combination Therapy For Functional Somatic Syndromes
Valaciclovir And Meloxicam Combination Therapy For Functional Somatic Syndromes
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/761059
Inventors:
William L. Pridgen - Tuscaloosa AL, US
International Classification:
A61K 31/5415, A61K 31/522
US Classification:
5142265
Abstract:
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound valaciclovir and a therapeutically-effective amount of the COX-2 inhibitor meloxicam. The invention is further related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of valaciclovir and meloxicam.
Aciclovir And Celecoxib Combination Therapy For Functional Somatic Syndromes
Aciclovir And Celecoxib Combination Therapy For Functional Somatic Syndromes
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/761071
Inventors:
William L. Pridgen - Tuscaloosa AL, US
International Classification:
A61K 31/522, A61K 31/415
US Classification:
51426338
Abstract:
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound aciclovir and a therapeutically-effective amount of the COX-2 inhibitor celecoxib. The invention is further related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of aciclovir and celecoxib.
Valaciclovir And Celecoxib Combination Therapy For Functional Somatic Syndromes
Valaciclovir And Celecoxib Combination Therapy For Functional Somatic Syndromes
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/761088
Inventors:
William L. Pridgen - Tuscaloosa AL, US
International Classification:
A61K 31/522, A61K 31/415
US Classification:
51426338
Abstract:
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound valaciclovir and a therapeutically-effective amount of the COX-2 inhibitor celecoxib. The invention is further related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of valaciclovir and celecoxib.
Famciclovir And Diclofenac Combination Therapy For Functional Somatic Syndromes
Famciclovir And Diclofenac Combination Therapy For Functional Somatic Syndromes
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/761046
Inventors:
William L. Pridgen - Tuscaloosa AL, US
International Classification:
A61K 31/52, A61K 31/196
US Classification:
5142634, 206570
Abstract:
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound famciclovir and a therapeutically-effective amount of the COX-2 inhibitor diclofenac. The invention is further related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of famciclovir and diclofenac.
Aciclovir And Diclofenac Combination Therapy For Functional Somatic Syndromes
Aciclovir And Diclofenac Combination Therapy For Functional Somatic Syndromes
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/761083
Inventors:
William L. Pridgen - Tuscaloosa AL, US
International Classification:
A61K 31/522, A61K 31/196
US Classification:
51426338
Abstract:
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound aciclovir and a therapeutically-effective amount of the COX-2 inhibitor diclofenac. The invention is further related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of aciclovir and diclofenac.